OH HB629

Authorizes pharmacists to treat patients aged 13 and older for minor health conditions including influenza, strep throat, COVID, bronchitis, sinusitis, lice, skin conditions (ringworm, athlete's foot), urinary tract infections, and HIV prevention (pre- and post-exposure prophylaxis) under a protocol established by a physician, nurse practitioner, or physician assistant practicing within 40 miles of the pharmacy.

Permits pharmacists to order and perform CLIA-waived diagnostic tests, evaluate test results, and prescribe non-controlled drugs and drug therapy devices as part of treatment, with a requirement to perform a diagnostic test before prescribing for strep throat.

Allows pharmacists to independently prescribe and administer tuberculin skin tests for tuberculosis screening after completing CDC-approved training, with mandatory reporting of positive results and referral to health care providers within 40 miles.

Requires health insurers and public employee benefit plans to reimburse pharmacists for services provided under these new prescribing authorities if the plan covers the same service when provided by other licensed prescribers.

Adds pharmacists who prescribe under these new sections to the statutory definition of "licensed health professional authorized to prescribe drugs" and requires the State Board of Pharmacy to adopt implementing rules in consultation with the State Medical Board and Board of Nursing.